ZA962753B - 1,3-Dihydro-2H-imidazol-2-one derivatives. - Google Patents
1,3-Dihydro-2H-imidazol-2-one derivatives.Info
- Publication number
- ZA962753B ZA962753B ZA9602753A ZA962753A ZA962753B ZA 962753 B ZA962753 B ZA 962753B ZA 9602753 A ZA9602753 A ZA 9602753A ZA 962753 A ZA962753 A ZA 962753A ZA 962753 B ZA962753 B ZA 962753B
- Authority
- ZA
- South Africa
- Prior art keywords
- imidazol
- dihydro
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95200870 | 1995-04-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA962753B true ZA962753B (en) | 1997-10-06 |
Family
ID=8220175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9602753A ZA962753B (en) | 1995-04-06 | 1996-04-04 | 1,3-Dihydro-2H-imidazol-2-one derivatives. |
Country Status (15)
Country | Link |
---|---|
US (1) | US5869515A (de) |
EP (1) | EP0832071B1 (de) |
JP (1) | JP4115519B2 (de) |
KR (1) | KR100400159B1 (de) |
CN (1) | CN1103760C (de) |
AR (1) | AR002984A1 (de) |
AT (1) | ATE305455T1 (de) |
CA (1) | CA2216542C (de) |
DE (1) | DE69635224T2 (de) |
ES (1) | ES2250988T3 (de) |
IL (1) | IL117806A (de) |
MY (1) | MY117936A (de) |
TW (1) | TW375612B (de) |
WO (1) | WO1996031487A1 (de) |
ZA (1) | ZA962753B (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5922751A (en) * | 1994-06-24 | 1999-07-13 | Euro-Celtique, S.A. | Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same |
BR9712256B1 (pt) * | 1996-10-02 | 2011-04-19 | composto derivado de 2-ciano imino imidazol, processo de preparação do mesmo e composição. | |
ES2211061T3 (es) * | 1998-04-01 | 2004-07-01 | Janssen Pharmaceutica N.V. | Derivados piridinicos que inhiben pde iv. |
AU777012B2 (en) | 1999-08-21 | 2004-09-30 | Takeda Gmbh | Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonist |
US20030175314A1 (en) * | 2001-11-19 | 2003-09-18 | Didriksen Erik Johannes | Pharmaceutical composition for dermal application |
FR2860514A1 (fr) * | 2003-10-03 | 2005-04-08 | Sanofi Synthelabo | Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique |
GEP20084550B (en) | 2004-04-30 | 2008-11-25 | Warner Lambert Co | Substituted morpholine compounds for the treatment of central nervous system disorders |
WO2006078698A1 (en) * | 2005-01-19 | 2006-07-27 | Cengent Therapeutics, Inc. | 2-imidazolone and 2-imidazolidinone heterocyclic inhibitors of tyrosine phosphatases |
US8354434B2 (en) * | 2006-01-30 | 2013-01-15 | Purdue Pharma L.P. | Cyclourea compounds as calcium channel blockers |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4636516A (en) * | 1981-02-19 | 1987-01-13 | Yamanouchi Pharmaceutical Co., Ltd. | 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds |
CA1309096C (en) * | 1985-08-13 | 1992-10-20 | Sumitomo Chemical Co., Ltd. | Butenoic acid derivatives, and their production and use |
US4845233A (en) * | 1987-09-11 | 1989-07-04 | Iprx, Inc. | Imidazolin-2-ones |
US5401851A (en) * | 1992-06-03 | 1995-03-28 | Eli Lilly And Company | Angiotensin II antagonists |
CA2140441C (en) * | 1992-07-28 | 2006-11-21 | Garry Fenton | Inhibitors of c-amp phosphodiesterase and tnf |
JP3775685B2 (ja) * | 1993-07-28 | 2006-05-17 | ローン−プーラン・ロレ・リミテツド | Pde▲iv▼およびtnf抑制剤としての化合物 |
GB9401460D0 (en) * | 1994-01-26 | 1994-03-23 | Rhone Poulenc Rorer Ltd | Compositions of matter |
GB9412672D0 (en) * | 1994-06-23 | 1994-08-10 | Celltech Ltd | Chemical compounds |
EP0766676B1 (de) * | 1994-06-24 | 2002-05-22 | Euroceltique S.A. | Verbindungen zur hemmung von phosphodiesrerase iv |
-
1996
- 1996-03-22 TW TW085103445A patent/TW375612B/zh not_active IP Right Cessation
- 1996-03-28 DE DE69635224T patent/DE69635224T2/de not_active Expired - Lifetime
- 1996-03-28 CA CA002216542A patent/CA2216542C/en not_active Expired - Lifetime
- 1996-03-28 ES ES96911969T patent/ES2250988T3/es not_active Expired - Lifetime
- 1996-03-28 WO PCT/EP1996/001393 patent/WO1996031487A1/en active IP Right Grant
- 1996-03-28 AT AT96911969T patent/ATE305455T1/de active
- 1996-03-28 CN CN96193104A patent/CN1103760C/zh not_active Expired - Lifetime
- 1996-03-28 US US08/930,478 patent/US5869515A/en not_active Expired - Lifetime
- 1996-03-28 EP EP96911969A patent/EP0832071B1/de not_active Expired - Lifetime
- 1996-03-28 JP JP52995896A patent/JP4115519B2/ja not_active Expired - Lifetime
- 1996-03-28 KR KR1019970706852A patent/KR100400159B1/ko not_active IP Right Cessation
- 1996-04-03 AR ARP960102075A patent/AR002984A1/es active IP Right Grant
- 1996-04-03 IL IL11780696A patent/IL117806A/xx not_active IP Right Cessation
- 1996-04-04 ZA ZA9602753A patent/ZA962753B/xx unknown
- 1996-04-05 MY MYPI96001299A patent/MY117936A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU5497996A (en) | 1996-10-23 |
ES2250988T3 (es) | 2006-04-16 |
CA2216542C (en) | 2009-01-13 |
MY117936A (en) | 2004-08-30 |
DE69635224T2 (de) | 2006-06-22 |
CN1181073A (zh) | 1998-05-06 |
EP0832071A1 (de) | 1998-04-01 |
DE69635224D1 (de) | 2006-02-09 |
KR100400159B1 (ko) | 2003-12-31 |
WO1996031487A1 (en) | 1996-10-10 |
TW375612B (en) | 1999-12-01 |
US5869515A (en) | 1999-02-09 |
CA2216542A1 (en) | 1996-10-10 |
ATE305455T1 (de) | 2005-10-15 |
CN1103760C (zh) | 2003-03-26 |
AR002984A1 (es) | 1998-05-27 |
JPH11504003A (ja) | 1999-04-06 |
KR19980703448A (ko) | 1998-11-05 |
EP0832071B1 (de) | 2005-09-28 |
IL117806A (en) | 2000-02-17 |
JP4115519B2 (ja) | 2008-07-09 |
AU697390B2 (en) | 1998-10-01 |
IL117806A0 (en) | 1996-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA961444B (en) | Pyrazolylbenzoyl derivatives. | |
ZA977687B (en) | Substituted 6,5-hetero-bicyclic derivatives | |
IL128049A0 (en) | Substituted 6,6-hetero-bicyclic derivatives | |
MX213417B (es) | Fenilpiridazinonas. | |
HK1010196A1 (en) | Novel 2,3-dioxo-1,2,3,4-tetrahdro-quinoyxalinyl derivatives. | |
ZA961449B (en) | Isoxazolylbenzoyl derivatives. | |
ZA961955B (en) | Indazolecarboxamides. | |
EP0845457A4 (de) | 2,2-dideutero-5-aminolevulinsäure | |
ZA969973B (en) | 2-thioxo-imidazolidin-4-one derivatives. | |
AU6123196A (en) | N-aryl-1,2,4-triazolin-5-ones | |
ZA973984B (en) | 2,4-diaminopyrimidine derivatives. | |
DE69610844D1 (en) | Hydroformylierungsverfahren. | |
ZA945238B (en) | 1,5 Benzodiazepine derivatives. | |
ZA962755B (en) | 1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives. | |
ZA967741B (en) | Diarylalkenylamine derivatives. | |
ZA962753B (en) | 1,3-Dihydro-2H-imidazol-2-one derivatives. | |
ZA962821B (en) | 4-indolylpiperazinyl derivatives. | |
ZA969625B (en) | 25-Hydroxy-16-ene-26, 27-bishomo-cholecalciferols | |
ZA967357B (en) | Pyrazol-4-ylbenzoyl derivatives. | |
ZA965465B (en) | 2,4,5-Trisubstituted phenylketoenois | |
ZA972302B (en) | 1,25-Dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives. | |
ZA964034B (en) | N-aminopyridone derivatives. | |
ZA965713B (en) | 5-pyrazolylbenzoic acid derivatives. | |
ZA969560B (en) | Substituted 1-methyl-3-phenylpyrazoles. | |
ZA964692B (en) | Benzimidazole derivatives. |